Systematic review of quality of life in Turner syndrome
This study aimed to systematically review the available literature on “quality of life” (QoL) or “health-related quality of life” (HRQoL) in Turner syndrome (TS) patients and to analyze the relations among height, puberty, and the use of growth hormone (GH) and the QoL of TS patients.
An electronic bibliographic search was conducted through the PubMed, Embase, Bireme, Scopus, and Web of Science databases. The main terms were “Quality of Life” and “Turner syndrome.”
Among the databases, 559 articles were found; after the selection process, 13 studies were selected. A quality assessment was conducted, and all the studies were of high quality. Eight well-known QoL questionnaires were used, and the selected studies presented factors that may be related to the QoL of TS patients, such as height, puberty, and GH use. However, a more detailed understanding of which factors are associated with the QoL of TS patients is still needed, which may be due to the lack of specific QoL instruments involving important aspects related to TS.
The QoL of TS patients appears to be compromised, but existing data regarding the relations among height, puberty, and GH and QoL are still controversial. Although these factors should be carefully considered in TS patients, it was not possible to determine whether they have a significant relation with the QoL of TS patients.
KeywordsQuality of life Turner syndrome Body height Puberty Growth hormone
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 26.Freriks, K., Verhaak, C. M., Sas, T. C. J., Menke, L. A., Wit, J. M., Otten, B. J., et al. (2015). Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social - emotional functioning in young adults with Turner syndrome. Hormones and Behavior, 69, 59–67.CrossRefPubMedGoogle Scholar
- 31.Naess, E. E., Bahr, D., & Gravholt, C. H. (2010). Health status in women with Turner syndrome—a questionnaire study on health status, education, work participation and aspects of sexual functioning. Clinical Endocrinology, 72, 678–684. https://doi.org/10.1111/j.1365-2265.2009.03715.x.CrossRefPubMedGoogle Scholar
- 34.Carel, J. C., Elie, C., Ecosse, E., Tauber, M., Léger, J., Sylvie, & Cabrol (2006). Self-esteem and social adjustment in young women with Turner syndrome- influence of pubertal management and sexuality: Population- based cohort study. Journal of Clinical Endocrinology and Metabolism, 91(80), 2972–2979.CrossRefPubMedGoogle Scholar
- 35.Carel, J. C., Ecosse, E., Bastie-Sigeac, I., Cabrol, S., Tauber, M., Leger, J., et al. (2005). Quality of life determinants in young women with Turner’s syndrome after growth hormone treatment: Results of the StaTur population-based cohort study. Journal of Clinical Endocrinology and Metabolism, 90, 1992–1997.CrossRefPubMedGoogle Scholar
- 38.Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009). When does it make sense to perform a meta-analysis?, in introduction to meta-analysis. Chichester: Wiley.Google Scholar
- 39.Higgins, J.P.T, & Green, S. (Eds.)., Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org.